Prescription drug prices are outrageously high. We need bold action to take on big pharma monopolies and drastically lower drug prices.
The Medicare Negotiation and Competitive Licensing Act of 2019 (H.R. 1046), from Reps. Lloyd Doggett (D-TX), Peter Welch (D-VT) and Elijah Cummings (D-MD) will finally allow Medicare to negotiate drug prices. And because this bill will receive massive resistance from the pharmaceutical industry, Doggett and his colleagues have crafted the bill with real teeth. If a drug company refuses to negotiate in good faith, the bill empowers the government to allow generic competition and end the company’s monopoly.
Today, we’re joining with our friends at Indivisible and allies across the country to drive thousands of calls to Congress demanding bold action to lower drug prices now!
Big pharma companies are endangering all of our lives and health, just to enrich their CEOs and shareholders. Now is not the time for half measures. Americans are coming together to demand action!
Comments